C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) G01N 33/53 (2006.01)
Patent
CA 2683685
The present invention relates to a screening method for classifying and for deciding to apply chemotherapy to patients suffering from non-small-cell lung cancer (NSCLC), based on detecting the levels of EGFR, CSF-1 and CA IX.
La présente invention concerne un procédé de dépistage pour classer et pour décider d'appliquer une chimiothérapie à des patients atteints d'un cancer du poumon non à petites cellules (NSCLC) en se basant sur la détection des niveaux d'EGFR, de CSF-1 et de CA IX.
Costa Rafael Rosell
Taron Roca Miguel
Pangaea Biotech S.a.
Perry + Currier
LandOfFree
Method of determining a chemotherapeutic regime and survival... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of determining a chemotherapeutic regime and survival..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of determining a chemotherapeutic regime and survival... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1944150